Vaccibody is a leading clinical-stage biopharmaceutical company that is dedicated to breaking boundaries and revolutionizing drug design. With their intelligent modular platform and tailored hyper-targeting, they are unlocking unlimited possibilities for the future of medicine. Inspired by their strong core values, Vaccibody's mission is to expedite the development of their existing assets, explore the potential of their platform to expand their pipeline, and build strategic partnerships to complement their strengths.

Their board of directors, with unrivaled collective experience, steers and supports this fast-moving company, while their management team maximizes the value of their platform and delivers their vision. Founded in 2006 in Oslo, Norway, Vaccibody is built on groundbreaking technology developed at the University of Oslo and Oslo University Hospital. With headquarters in Norway and an office in Denmark, Vaccibody is at the forefront of innovation in the biopharmaceutical industry